Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1566 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Pfizer Releases New Data On Celebrex

In the trial, the difference was driven by a decrease in hemoglobin and/or hematocrit of defined or presumed GI origin. Pfizer claimed that Condor (Celecoxib vs Omeprazole and

Ricerca Biosciences Receives DEA License

Ricerca offers a spectrum of services for the areas of agrochemical registration, environmental analysis and preclinical discovery and development for biopharmaceutical registration. Ricerca holds a current DEA license

OXiGENE To Commence Zybrestat Phase 2 Trial

OXiGENE said that an updated safety and outcome analysis of the Falcon trial has shown that trends towards improved outcomes were observed in response rate, progression-free survival and